StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MDCX

Medicus Pharma Ltd.

MDCXW Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.50
+0.00 +0.02%

Key statistics

from XBRL data in SEC filings
Market cap
$28.3M
Revenue (TTM)
Net income (TTM)
-$51.2M
EPS (TTM)
$-2.63
P/E ratio
Dividend yield
Free cash flow
Cash
$6.37M
Total assets
$7.43M
Gross margin
52-week range
$0.44 – $2.50

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 4, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Delisting notice or listing-rule failure May 27, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 29, 2026 8-K Entered a material agreement; Delisting notice or listing-rule failure Apr 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Unregistered sale of equity Mar 6, 2026 8-K Entered a material agreement Dec 30, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 8, 2025 8-K Director or officer change; Regulation FD disclosure Dec 1, 2025 8-K Other events Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Unregistered sale of equity Oct 17, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Sep 18, 2025 8-K Director or officer change Sep 12, 2025 8-K Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Other events Sep 2, 2025 8-K Unregistered sale of equity; Other events Aug 22, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Other events Aug 4, 2025 8-K Other events Jul 30, 2025 8-K Shareholder vote results; Other events Jul 23, 2025 8-K Entered a material agreement; Unregistered sale of equity Jul 14, 2025 8-K/A FORM 8-K/A Jul 3, 2025 8-K Entered a material agreement; Other events Jun 30, 2025 8-K Director or officer change; Other events Jun 23, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jun 20, 2025 8-K Changed accountants Jun 5, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Entered a material agreement; Took on a direct financial obligation May 5, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Other events Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Other events Mar 25, 2025 8-K Other events Mar 20, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 11, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Feb 11, 2025 6-K FORM 6-K Dec 26, 2024 6-K FORM 6-K Dec 12, 2024 6-K FORM 6-K Dec 2, 2024